leucyl-aspartyl-valine has been researched along with carbachol in 1 studies
*Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. [MeSH]
*Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. [MeSH]
| Studies (leucyl-aspartyl-valine) | Trials (leucyl-aspartyl-valine) | Recent Studies (post-2010) (leucyl-aspartyl-valine) | Studies (carbachol) | Trials (carbachol) | Recent Studies (post-2010) (carbachol) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 13,918 | 81 | 968 |
| Protein | Taxonomy | leucyl-aspartyl-valine (IC50) | carbachol (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.7849 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.0626 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.4134 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.535 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.6638 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.849 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WM; Adams, SP; Ateeq, HS; Castro, A; Chen, LL; Chong, LT; Gill, A; Hammond, CE; Hsiung, SH; Kalkunte, S; Lee, WC; Leone, DR; Lin, Kc; Lobb, RR; Pepinsky, RB; Sprague, AG; Zimmerman, CN | 1 |
1 other study(ies) available for leucyl-aspartyl-valine and carbachol
| Article | Year |
|---|---|
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
Topics: Animals; Anti-Allergic Agents; Binding Sites; Bronchial Hyperreactivity; Carbachol; Cell Adhesion; Cell Line; Drug Design; Epitopes; Fibronectins; Humans; Integrin alpha4beta1; Integrins; Jurkat Cells; Kinetics; Ligands; Oligopeptides; Receptors, Lymphocyte Homing; Sheep; Structure-Activity Relationship; Vascular Cell Adhesion Molecule-1 | 1999 |